United Therapeutics Corp (UTHR.OQ)
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|62||2016||Chairman of the Board, Chief Executive Officer|
|45||2016||President, Chief Operating Officer|
|53||2007||Lead Independent Vice Chairman of the Board|
|49||2015||Chief Financial Officer, Treasurer|
|53||2003||Executive Vice President, General Counsel, Corporate Secretary|
- BRIEF-United Therapeutics Says FDA Accepted To Review Its NDA For Implantable System For Remodulin
- BRIEF-United Therapeutics Corp Reports Qtrly EPS Of $0.43
- BRIEF-United Therapeutics Settles Patent Litigation With Actavis Laboratories FL
- BRIEF-Celularity Announces Formation Of Co With $250 Mln In Funding From Celgene, United Therapeutics, Others
- BRIEF-Corsair Pharma And United Therapeutics Enter Into Strategic Collaboration To Advance Novel Treprostinil Prodrugs